Zebra Medical Vision has launched its new imaging analytics platform called Deep Learning Analytics Engine in Europe, Australia and New Zealand, following the grant of CE mark and respective regulatory approvals.

The machine learning imaging analytics solution is designed to aid physicians and healthcare providers in offering better patient care.

The engine automatically analyses imaging data and allows radiologists to deliver quick, accurate and comprehensive reports.

Compatible with PACS, RIS, Reporting and EMR systems, the platform is said to enable seamless flow for physicians.

Zebra Medical Vision co-founder and CEO Elad Benjamin said: “These recent regulatory approvals allow us to continue driving adoption of our Analytics Engine globally, where we see significant interest in countries that have a problematic ratio of radiologists per capita.

“Providing tools that assist them in delivering better care is critical and is the driving force behind our mission.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We have already begun working with luminary university hospitals in Europe, and will continue to expand our footprint across the region.”

"These recent regulatory approvals allow us to continue driving adoption of our Analytics Engine globally, where we see significant interest in countries that have a problematic ratio of radiologists per capita."

The Deep Learning Analytics Engine currently analyses CT data for signs of fatty liver, excess coronary calcium, emphysema, low bone density and vertebral compression fractures.

In the near future, the firm intends to add more than 12 new algorithms to the engine for the detection of life-threatening diseases.

The platform can be deployed in both cloud and on-premise configurations.

It enables healthcare organisations to identify chronic diseases earlier, providing them with the opportunity to determine preventative care programmes and improve the service provided, while minimising the overall treatment costs.


Image: Zebra Medical Vision. Photo: courtesy of Business Wire.